Context Therapeutics (CNTX) Other Operating Expenses (2024 - 2026)
Context Therapeutics (CNTX) posted Other Operating Expenses of -$7.4 million for Q1 2026, up 28.83% sequentially from -$10.5 million in Q4 2025, and down 66.48% YoY from -$22.2 million in Q1 2025.
Context Therapeutics (CNTX) Other Operating Expenses (2024 - 2026) Analysis & Trends
Context Therapeutics has reported Other Operating Expenses for 3 years, with the latest figure at -$7.4 million in Q1 2026.
- Quarterly Other Operating Expenses fell 66.48% year-over-year to -$7.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$35.5 million (down 38.28% YoY) and the FY2025 annual result came in at -$32.9 million, down 31.16% from the prior year.
- Other Operating Expenses climbed to -$7.4 million in Q1 2026 per CNTX's latest filing, from -$10.5 million in the prior quarter.
- Over five years, Other Operating Expenses peaked at -$3.1 million in Q2 2024 and troughed at -$10.5 million in Q4 2024.
- A 3-year average of -$7.2 million and a median of -$7.7 million in 2024 frame the typical range for Other Operating Expenses.
- The widest YoY moves for Other Operating Expenses: up 0.03% in 2025, down 167.76% in 2025.
- Over 3 years, Other Operating Expenses stood at -$10.5 million in 2024, then advanced by 0.03% to -$10.5 million in 2025, then rose by 28.83% to -$7.4 million in 2026.
- According to Business Quant data, Other Operating Expenses over the past three periods registered -$7.4 million, -$10.5 million, and -$9.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Context Therapeutics | 48.18 Mn | 48.18 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -7.44 Mn |
| Mar 31, 2026 | -7.44 Mn |
| Dec 31, 2025 | -10.45 Mn |
| Sep 30, 2025 | -9.37 Mn |
| Jun 30, 2025 | -8.27 Mn |
| Mar 31, 2025 | -4.47 Mn |
| Dec 31, 2024 | -10.46 Mn |
| Sep 30, 2024 | -7.68 Mn |
| Jun 30, 2024 | -3.09 Mn |
| Mar 31, 2024 | -3.82 Mn |